Madrigal Pharmaceuticals MDGL

Levy Richard (Director) plans to sell 5,682 MDGL shares, about $2.9M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: May 22, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Previously Exercised Stock Options
  4. 10b5-1 plan adopted: Feb 20, 2026

All of Levy Richard's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 40 shares at $506.68 on May 22, 2026 · Form 4
  • Sold 320 shares at $508.24 on May 22, 2026 · Form 4
  • Sold 151 shares at $510.36 on May 22, 2026 · Form 4
  • Sold 610 shares at $511.4 on May 22, 2026 · Form 4
  • Sold 439 shares at $512.5 on May 22, 2026 · Form 4
  • Sold 40 shares at $512.97 on May 22, 2026 · Form 4
  • Sold 343 shares at $514.67 on May 22, 2026 · Form 4
  • Sold 657 shares at $515.92 on May 22, 2026 · Form 4
  • Sold 723 shares at $516.87 on May 22, 2026 · Form 4
  • Sold 1,497 shares at $517.59 on May 22, 2026 · Form 4
  • Sold 782 shares at $518.76 on May 22, 2026 · Form 4
  • Sold 80 shares at $519.98 on May 22, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Get an email when Madrigal Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.